Ana
Moreno Álvarez
Hospital Infantil Universitario Niño Jesus de Madrid
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Infantil Universitario Niño Jesus de Madrid (10)
2024
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
-
Erratum: Correction to: Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP (European journal of pediatrics (2024) 183 8 DOI: 10.1007/s00431-024-05575-7)
European journal of pediatrics
-
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP
European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3417-3430
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
2021
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
-
Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease
Pharmaceutics, Vol. 13, Núm. 1, pp. 1-17
2020
-
Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease
International Journal of Molecular Sciences, Vol. 21, Núm. 9
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515